Title
Where will it end? Pathways to care and catastrophic costs following negative TB evaluation in Uganda
Date Issued
01 July 2021
Access level
open access
Resource Type
journal article
Author(s)
Samuels T.H.A.
Shete P.B.
Ojok C.
Nalugwa T.
Farr K.
Turyahabwe S.
Katamba A.
Cattamanchi A.
University College London Hospitals NHS Foundation Trust
Publisher(s)
Public Library of Science
Abstract
Introduction Catastrophic costs incurred by tuberculosis (TB) patients have received considerable attention, however little is known about costs and pathways to care after a negative TB evaluation. Materials and methods We conducted a cross-sectional study of 70 patients with a negative TB evaluation at four community health centres in rural and peri-urban Uganda. Patients were traced 9 months post-evaluation using contact information from TB registers. We collected information on healthcare visits and implemented locally-validated costing questionnaires to assess the financial impact of their symptoms post-evaluation. Results Of 70 participants, 57 (81%) were traced and 53 completed the survey. 31/53 (58%) surveyed participants returned to healthcare facilities post-evaluation, making a median of 2 visits each (interquartile range [IQR] 1–3). 11.3% (95%CI 4.3–23.0%) of surveyed patients and 16.1% (95%CI 5.5–33.7%) of those returning to healthcare facilities incurred catastrophic costs (i.e., spent >20% annual household income). Indirect costs related to lost work represented 80% (IQR 32–100%) of total participant costs. Conclusions Patients with TB symptoms who experience financial catastrophe after negative TB evaluation may represent a larger absolute number of patients than those suffering from costs due to TB. They may not be captured by existing definitions of non-TB catastrophic health expenditure.
Volume
16
Issue
7 July
Language
English
OCDE Knowledge area
Medicina tropical
Scopus EID
2-s2.0-85110506059
PubMed ID
Source
PLoS ONE
Sponsor(s)
DJAM received a grant from the UK Medical Research Council (grant number MR/ M017362/1; https://mrc.ukri.org/). AC received a grant from the National Heart, Lung, and Blood Institute (grant number R01HL130192 https://www.nhlbi.nih.gov/). THAS received funding from the Masters Trust Fund at the London School of Hygiene and Tropical Medicine (Project Code ITCR 082010; www.lshtm.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Sources of information:
Directorio de Producción Científica
Scopus